SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Pharmachem informs about trading window closure

28 Sep 2024 Evaluate
Omkar Pharmachem has informed that the Trading Window for dealing in the securities of the Company will remain closed for the designated persons and their immediate relatives from Tuesday, 01st October 2024 till the completion of 48 hours after the date of declaration of Unaudited Financial Results of the Company for the Quarter and half year ended on 30th September, 2024.

The above information is a part of company’s filings submitted to BSE.

Omkar Pharmachem Share Price

28.03 0.00 (0.00%)
27-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×